Aldose reductase (alditol:NADP+ 1-oxidoreductase, EC 1.1.1.21) has been partially purified from human erythrocytes by DEAE-cellulose (DE-52) column chromatography. This enzyme Is activated severalfold upon incubation with 10 FmM each glucose 6-phosphate, NADPH, and glucose.
The activation of the enzyme was confirmed by following the oxidation of NADPH as well as the formation of sorbitol with glucose as substrate. The activated form of aldose reductase exhibited monophasic kinetics with both glyceraldehyde and glucose (Km of glucose = 0.68 mM and Km of glyceraldehyde = 0.096 mM), whereas the native (unactivated) enzyme exhibited biphasic kinetics (K. of glucose = 9.0 and 0.9 mM and Km of glyceraldehyde _ 1.1 and 0.14 mM). The unactivated enzyme was strongly inhibited by aldose reductase inhibitors such as sorbinil, alrestatin, and quercetrin, and by phosphorylated intermediates such as ADP, glycerate 3-phosphate, glycerate 1,3-bisphosphate, and glycerate 2,3-trisphosphate. The activated form of the enzyme was less susceptible to inhibition by aldose reductase inhibitors and phosphorylated intermediates.
Aldose reductase (alditol:NADP+ 1-oxidoreductase, EC 1.1.1.21) has been implicated in the etiology of complications of diabetes such as neuropathy, nephropathy, retinopathy, and cataractogenesis (1) (2) (3) (4) . This enzyme reduces glucose to sorbitol in the presence of NADPH. The major cause of the complications of diabetes could be the change in the osmotic pressure due to the accumulation of sorbitol, which is relatively impermeable through biological membranes (5) . Increased levels of sorbitol in the tissues of diabetic subjects and in diabetic animals have indeed been reported (6) (7) (8) (9) . In addition, incubation of human erythrocytes with increasing concentrations of glucose (30-50 mM) results in increased levels of sorbitol in the erythrocytes (10, 11) . The role of aldose reductase in the formation of sorbitol in the erythrocyte was further confirmed by lower levels of erythrocyte sorbitol in diabetic subjects receiving aldose reductase inhibitors such as sorbinil and alrestatin as compared with diabetic subjects receiving a placebo (12, 13 (14) . The pooled fraction containing aldose reductase essentially free from aldehyde reductase II was used for all subsequent studies.
Enzyme Activity Determination. Aldose reductase activity was determined as described (14) . Briefly, the reaction mixture in a 1-ml system contained 50 mM potassium phosphate (pH 6.0), 5 (17, 18) and also by HPLC. In a 1.0-ml NADPH recycling system (wherever specified), 50 mM potassium phosphate (pH 6.5) was incubated for 90 min at 370C with 5 mM 2-mercaptoethanol, 0.6 mM Glc-6-P, 100 milliunits of Glc-6-P dehydrogenase, 5 mM glucose containing 0.125 gCi of [1-14C] glucose (specific activity, 8.2 mCi/mmol; 1 Ci = 37 GBq), and DE-52-purified erythrocyte aldose reductase. The reaction was stopped with 0.2 ml of 1 M HCl and brought to pH 7.0 by addition of 1 M NaOH. Samples were centrifuged at 2,000 x g for 10 min, and aliquots of supernatant were used for sorbitol determination by HPLC and fluorometry.
In the fluorometric method, sorbitol was quantitated by following the reduction of NAD by sorbitol dehydrogenase (17, 18) using a Turner model 111 fluorometer. In the HPLC method, 10-50 ,l of the supernatant was injected onto a carbohydrate column (Bio-Rad 300 x 7.8 mm Aminex HPX-87P), equilibrated with water, flow rate 1 ml/min, at 76°C. Fractions of 0.5 ml were collected and the radioactivity was determined in Bray's solution (19) A distinct separation of glucose and sorbitol was achieved by HPLC (Fig. 1) . Approximately 17% of the total glucose was reduced to sorbitol. Similar results were also obtained by the fluorometric method. Therefore, in subsequent determinations, fluorometry was used.
In a regular enzyme determination system, the rate of NADPH oxidation as well as the rate of sorbitol formation 6.0 was also studied over a period of 25 min. The complete reaction mixture containing 5 mM glucose with and without Li2SO4 was incubated at 370C with the appropriate amount of aldose reductase, and oxidation of NADPH was followed spectrophotometrically. Aliquots were withdrawn at different time intervals for the quantitation of sorbitol by the fluorometric method.
Activation of Aldose Reductase. Conditions for the activation of erythrocyte aldose reductase were optimized with glucose, Glc-6-P, and NADPH individually and together. Incubation of the enzyme with 10 ,uM each of Glc-6-P, NADPH, and glucose for 20 min at 250C resulted in the maximum activation of the enzyme, which was unaffected by dialysis against buffer A. The dialyzed enzyme was designated "activated enzyme" and used for further studies. The enzyme that was not preincubated with activators was designated "unactivated" or "native enzyme."
RESULTS AND DISCUSSION
Effect of Glucose and Its Metabolites on the Erythrocyte Aldose Reductase. A significant increase in aldose reductase activity in the tissues of diabetic subjects and experimental animals has been reported (20) (21) (22) . In addition, incubation of human erythrocytes with various concentrations of glucose (30-50 mM) resulted in the accumulation of substantial amounts of sorbitol in the erythrocytes (10, 11) . These results indicate that glucose or one of its metabolites may be responsible for the increase in the enzyme activity, especially because erythrocytes cannot synthesize the enzyme de novo. One of the mechanisms of enzyme activation could be glucosylation of the enzyme protein.
In order to study the effect of glucose and its metabolites on erythrocyte aldose reductase, partially purified enzyme by DE-52 column chromatography was used. As described earlier (14) , DE-52 column chromatography completely separated aldose reductase and aldehyde reductase II of erythrocytes. Differentiation of aldose reductase from aldehyde reductase II was based upon substrate specificity, cofactor requirements, and immunological properties (14) . Aldose reductase can catalyze the reduction of glucose to sorbitol, uses NADPH as well as NADH as cofactors, and is precipitated by the antibodies raised against lens aldose reductase. Aldehyde reductase II does not utilize glucose as a substrate, exhibits an essential requirement for NADPH, and is precipitated with antiserum against placenta aldehyde reductase II but not with anti-lens aldose reductase antiserum.
Incubation of aldose reductase with 10 ,M each of NADPH, Glc-6-P, and glucose at 25°C for 20 min resulted in approximately a 7-fold increase in the enzyme activity ( Table  1 ). The activation of aldose reductase was comparatively less (4-to 6-fold) when outdated blood from the blood bank was used for the enzyme purification. Incubation of the enzyme with glucose alone did not activate the enzyme, whereas the incubation with Glc-6-P alone activated the enzyme approximately 3-fold. The enzyme remained activated even after thorough dialysis against buffer A or subjection to DE-52 column chromatography. In order to study whether the activated enzyme forms proportionate amounts of sorbitol when glucose is used as substrate, the formation of sorbitol was followed (Fig. 2) . Equal amounts of the native enzyme, purified by using outdated blood, was taken in two test tubes. In one tube the enzyme was incubated with 10 ,uM each ofGlc-6-P, NADPH, and glucose for 20 min at 25°C, with the other tube serving as control. In both tubes, the sorbitol formation was determined in a 1-ml system containing 5 mM glucose, 50 mM potassium phosphate (pH 6.0), 5 mM 2-mercaptoethanol, and 0.1 mM NADPH. The tubes were incubated at 370C, and aliquots were withdrawn at different time intervals for sorbitol deter- for the expression of aldose reductase activity by homogenous preparations from human erythrocytes and other tissues (15, (23) (24) (25) .
The formation of sorbitol by activated and unactivated enzyme was also studied by following the competition between glyceraldehyde and glucose for the substrate binding site on aldose reductase. Various concentrations of glyceraldehyde (0-10 mM) were added to the NADPH recycling system for aldose reductase activity determination containing a fixed amount of glucose (5 mM). Samples were incubated at 37°C for 15 min, and the amount of sorbitol formed was determined fluorometrically. The results shown in Fig. 3 indicate that glyceraldehyde effectively competes with glucose for the binding center on both activated and unactivated aldose reductase. Only 0.2 mM glyceraldehyde was required for approximately a 50% decrease in the reduction of glucose because the Km of aldose reductase for glyceraldehyde is almost 1/10th that for glucose.
Since Glc-6-P activated aldose reductase, the effect of various other phosphorylated intermediates of the glycolytic pathway, such as fructose 6-phosphate, fructose 1,6-bisphosphate, glyceraldehyde 3-phosphate, dihydroxyacetone phosphate, glycerate 1,3-bisphosphate, glycerate 2,3-bisphosphate, glycerate 3-phosphate, phosphoenolpyruvate, AMP, ADP, and ATP on the activated and unactivated enzyme was studied. Both the activated and unactivated erythrocyte aldose reductase were incubated with 15 ,uM phosphorylated intermediates for 4 min at 37°C, and the enzyme activity was determined as described above. The unactivated enzyme was completely inhibited by glycerate 3-phosphate, glycerate 1,3-bisphosphate, glycerate 2,3-bisphosphate, and ADP, whereas these inhibitors had no effect on the activated enzyme ( Table 2 ). The inhibition of the unactivated enzyme was not reversible even after a thorough dialysis against buffer A. None of the other intermediates had any significant effect on the activated or unactivated enzymes. Physiological concentrations of glycerate 3-phosphate (0.045 mM), glycerate 2,3-bisphosphate (4.2 mM), and ADP (0.22 mM) (26) , besides completely inhibiting the unactivated aldose reductase, inhibited the activated enzyme also by 30-40%. However, significant amounts of these phosphorylated compounds may not exist in vivo in free form. Physiological concentrations of other phosphorylated intermediates had no effect on the activated or the unactivated enzyme.
Kinetic Properties of the Unactivated and Activated Aldose
Reductase. The unactivated enzyme exhibited a biphasic curve with glucose (Km = 9 and 0.9 mM) and with glyceraldehyde (Km = 1.1 and 0.14 mM) (Fig. 4) Formation of a significant amount of sorbitol in the erythrocytes of diabetic subjects having high blood glucose levels (10, 28) would indicate that a significant portion of the erythrocyte aldose reductase remains activated. We have indeed preliminary results that suggest that whenever blood glucose concentration in diabetic subjects is more than 15 mM, all ofthe erythrocyte aldose reductase is in the activated form (29) . This enzyme exhibits properties similar to the in vitro activated erythrocyte aldose reductase. This would indicate that much higher concentrations of aldose reductase inhibitors will be required to completely inhibit erythrocyte aldose reductase in diabetic subjects. In fact, in clinical trials, the concentration of plasma sorbinil and alrestatin had to be maintained at approximately 50 AM (12) and 900 ,M (13), respectively, to significantly lower the sorbitol concentration in erythrocytes of diabetic subjects and experimental animals, whereas approximately 20 ,uM sorbinil and 100 ,M alrestatin almost completely inhibit the enzyme activity in vitro (30) .
Activation of aldose reductase is not unique to erythrocytes. The enzyme of other human tissues such as lens, brain, aorta, and muscle also exists in the activated and unactivated forms and the unactivated form of aldose reductase can be activated to various degrees under conditions used for the activation of erythrocyte enzyme (29, 31) . If aldose reductase is involved in the etiology of the complications of diabetes such as cataractogenesis, neuropathy, nephropathy, and retinopathy, our demonstration of the phenomenon of aldose reductase activation would significantly help in understanding the pathophysiology of these complications.
This investigation was supported in part by Public Health Service Grant EY 01677 awarded by the National Eye Institute .   FIG. 4 . Lineweaver-Burk plots of the activated (o) and unactivated (0) forms of human erythrocyte aldose reductase with glyceraldehyde (Right) and glucose (Left) as substrates. Enzyme activity was determined as described in the text with NADPH being added prior to the addition of substrate. Activation of aldose reductase was performed by incubating the enzyme with 10 ,uM each of Glc-6-P, NADPH, and glucose for 20 min at 25°C, followed by overnight dialysis against 1000 vol of buffer A. The amount of activated enzyme used in these studies was about 1/10th that of unactivated enzyme, so that the determined enzyme activities were almost equal.
[s], Substrate concentration; V, velocity, units/ml.
